OST4

OST4 is a minimal single-pass transmembrane subunit of the oligosaccharyltransferase (OST) complex that stabilizes the association between the catalytic STT3 subunit and the oxidoreductase-fold subunits (Ost3/Ost6 in yeast; ribophorin I in mammals), thereby ensuring efficient N-linked glycosylation of nascent polypeptides in the endoplasmic reticulum. Its transmembrane α-helix makes direct hydrophobic contacts with TM12/TM13 of STT3, and point mutations in this helix (e.g., V23D) disrupt these contacts and destabilize the assembled complex (PMID:12810948, PMID:33442744). Loss of OST4 prevents incorporation of Ost3/Ost6 paralogs into distinct yeast OST isoforms, and in mammalian cells siRNA depletion of OST4 preferentially impairs co-translational N-glycosylation mediated by the STT3A-containing complex (PMID:16096346, PMID:23606741). Mislocalized Ost4 that reaches the mitochondrial outer membrane is extracted by the AAA+ ATPase Msp1, constituting a quality-control pathway for this small tail-anchored-like protein (PMID:40236206).

1. 1996 High

   Identifying OST4 as a subunit of the oligosaccharyltransferase answered whether the enzymatic complex required an unusually small (~3.6 kDa) protein for activity, establishing that loss of this tiny ORF greatly diminishes N-glycosylation both in vivo and in vitro.

   Evidence Gene disruption in yeast with in vivo and in vitro OTase activity assays

   PMID:8621712

   Open questions at the time

   • Mechanism by which Ost4p contributes to OTase activity unknown
   • Physical association with the OST complex not yet demonstrated
   • Whether a mammalian ortholog exists and has the same role
2. 1997 High

   Demonstrating that Ost4p forms a stable subcomplex with Stt3p and Ost3p resolved its position within the multi-subunit OST architecture, and genetic suppression of stt3 mutants by OST4 overexpression established a direct functional link to the catalytic subunit.

   Evidence Epitope-tag co-immunoprecipitation with mild denaturation subcomplex analysis; genetic suppressor assay in yeast

   PMID:9405463 PMID:9435788

   Open questions at the time

   • Topology and precise membrane-embedded contacts of Ost4p unknown
   • Whether Ost4p interacts with the Ost6p paralog as well as Ost3p
3. 2003 High

   Mapping the type I membrane topology and showing that ionizable substitutions in the transmembrane helix (residues 18–25) break both Ost4p–Stt3p and Ost4p–Ost3p interactions established that Ost4p bridges these two subunits through hydrophobic contacts in the membrane.

   Evidence In vivo topology determination, site-directed mutagenesis with co-IP, and CD spectroscopy of synthetic Ost4p in liposomes

   PMID:12810948

   Open questions at the time

   • Atomic-resolution structure of the Ost4–Stt3 interface not available
   • Whether the bridging role extends to the Ost6p-containing isoform
4. 2005 High

   Blue native gel analysis of ost4Δ strains showed that Ost4p is required for incorporating both Ost3p and Ost6p paralogs into their respective OST isoforms, establishing Ost4p as a universal assembly factor for these functionally distinct complexes.

   Evidence Blue native PAGE and immunodetection in wild-type vs. ost4Δ yeast

   PMID:16096346

   Open questions at the time

   • Whether loss of Ost4p differentially affects substrate specificity of Ost3p- vs. Ost6p-containing complexes
   • Mechanism by which Ost4p stabilizes both paralog-specific isoforms
5. 2011 Medium

   Determination of the human OST4 NMR structure revealed an α-helical transmembrane domain with a kink, providing the first structural framework for understanding how this minimal protein integrates into the OST complex.

   Evidence Solution NMR spectroscopy of human OST4

   PMID:21609714

   Open questions at the time

   • Functional significance of the helical kink not directly tested
   • Structure determined in organic solvent, not in a membrane-like environment
6. 2013 High

   Characterizing human OST4 in mammalian cells showed it assembles into both STT3A- and STT3B-containing OST complexes, and its depletion preferentially impairs co-translational glycosylation, thereby translating the yeast findings to the mammalian system and revealing isoform-specific functional consequences.

   Evidence Co-IP, site-directed mutagenesis, siRNA knockdown, blue native PAGE, and prosaposin glycosylation assay in HeLa cells

   PMID:23606741

   Open questions at the time

   • Why STT3A-containing complexes are more sensitive to OST4 loss than STT3B-containing complexes
   • No in vivo animal model of OST4 deficiency
7. 2021 High

   NMR structures and MD simulations of the V23D mutant provided an atomic-level explanation for complex destabilization: the mutation exposes a charged residue into a hydrophobic pocket at the Ost4–Stt3 TM12/TM13 interface, resolving the structural basis of decades-old genetic observations.

   Evidence NMR structure of wild-type and V23D Ost4 in micelles; MD simulations of the membrane-embedded OST complex

   PMID:33442744

   Open questions at the time

   • No cryo-EM structure of the complete OST with resolved Ost4 at high resolution
   • Whether the V23D-equivalent mutation has the same effect in the mammalian complex
8. 2025 Medium

   Identification of mislocalized Ost4 as an Msp1 substrate at the mitochondrial outer membrane revealed a quality-control pathway that clears this small ER-targeted protein when it is mis-inserted, expanding the known biology of OST4 beyond OST complex function.

   Evidence Msp1-protease chimera substrate trapping with mass spectrometry and topology experiments in yeast (preprint)

   PMID:40236206

   Open questions at the time

   • Not yet peer-reviewed; awaits independent validation
   • Whether mammalian ATAD1 performs the same clearance role for mislocalized OST4
   • Fraction of newly synthesized Ost4 that mis-targets to mitochondria under normal conditions

• Outstanding questions include whether OST4 loss causes a recognizable human glycosylation disorder, the high-resolution cryo-EM structure of OST4 within the intact mammalian OST complex, and the mechanistic basis for the differential sensitivity of STT3A- versus STT3B-containing complexes to OST4 depletion.
• No disease-associated mutations in human OST4 reported in the literature
• No high-resolution structure of OST4 within the intact mammalian OST
• Differential dependence of STT3A vs. STT3B complexes on OST4 unexplained